Invention Grant
- Patent Title: Insulin-Fc fusions and methods of use
-
Application No.: US16438681Application Date: 2019-06-12
-
Publication No.: US10597435B2Publication Date: 2020-03-24
- Inventor: Thomas M. Lancaster , Todd C. Zion , Thillainayagam Sathiyaseelan , Sylaja Murikipudi
- Applicant: Akston Biosciences Corporation
- Applicant Address: US MA Beverly
- Assignee: Akston Biosciences Corporation
- Current Assignee: Akston Biosciences Corporation
- Current Assignee Address: US MA Beverly
- Agency: Reichel Stohry Dean LLP
- Agent Mark C. Reichel; Natalie J. Dean
- Main IPC: A61K38/28
- IPC: A61K38/28 ; C07K14/62 ; A61P3/10 ; A61K38/00
Abstract:
The present disclosure relates generally to compositions of insulin-Fc (e.g., proinsulin-Fc) fusion proteins and their use to treat autoimmune disease, e.g., autoimmune diabetes, e.g., Type 1 diabetes.
Public/Granted literature
- US20190315828A1 INSULIN-FC FUSIONS AND METHODS OF USE Public/Granted day:2019-10-17
Information query
IPC分类:
